PGY-1 GenSurg Resident at Loma Linda Health Research Collaborator at Mayo Clinic Arizona
Joined March 2022
- Tweets13
- Following37
- Followers19
- Likes7
Hor Hoe Yan retweeted
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Hor Hoe Yan retweeted
👏 A standing ovation at ASCO for results of the RASolute302 study looking at Daraxonrasib vs Chemo for metastatic pancreatic cancer. The wall has finally been breached for targeted therapy in tumors driven by RAS gene mutations 🧱 👊 !
nejm.org/doi/full/10.1056/NE…
Hor Hoe Yan retweeted
Bummed I couldn’t make it to SAGES this year but super proud of everyone’s hard-work and their mentors! @anushkapal12 @AZevallosMD @Thaersh96 #hoeyanhor #maryoh #mohamedelfarra @SAGES_Updates
Thank you for the opportunity to present in the plenary session at SAGES 2026.
✔️No clinical significance when comparing open Vs laparoscopic Vs robotic inguinal hernia repair
😶🌫️Surgeons should choose repair modality according individual preferences and experience
#sages2026
Hor Hoe Yan retweeted
Thanks @JNCCN for publishing our work, the first author and our primary workhorse @TanPoHong2, and our group at large for making this work possible.
@ThielsCA @KPoruk_MD @HorHoeYan @Chee_CheeStucky @DrRickBold @TELL_Starlinger @johnstauffer
Hor Hoe Yan retweeted
1/ When starting a🤖Whipple program, struggle is always balancing patient selection for safe completion vs⬇️volume w being selective.
We asked if it was safe w being liberal w pt selection w a lower threshold to convert for non-progression. Results in🧵!
sciencedirect.com/science/ar…
Excited to share that our work @melodytu_ on 'Robotic Modified Puestow Procedure for Chronic Pancreatitis' is now published in @JournalofGISurg !
Grateful for the incredible mentorship from @ZhiVenFongMD in @MayoAZSurg . 😃
Read in full: jogs.org/article/S1091-255X(…
Thrilled to share that our abstract on Recurrence after Open vs Laparoscopic vs Robotic Inguinal Hernia Repair, mentored by @PeiWenLimMD & @ZhiVenFongMD at @MayoAZSurg has been accepted as a PLENARY PODIUM presentation at #SAGES2026. Proud to present it as a @LLUHealth's resident
Hor Hoe Yan retweeted
Congrats to @LLUSurgOnc PGY1 @HorHoeYan presenting an elegant video from his research time at @MayoAZSurg with @ZhiVenFongMD on robotically removing a symptomatic abdominal AVM 🪢 @AmCollSurgeons #ACSCC25
Hor Hoe Yan retweeted
Last week, @MayoAZSurg had great representation at @SWSCongress.
@egbert_lena (PI: #BarbPockaj) had an oral presentation on trends & outcomes in axillary management of breast cancer in the elderly, which also won 1st place at @MayoClinic’s 26th Annual Academic Excellence Day!
Signet Cell Adenocarcinoma of the Appendix (SRCA). Poor prognosis disease but COMPLETE CYTOREDUCTION with surgical debulking and HIPEC is the key to improve survival! Honoured to be able to present this at Southwestern Surgical Congress #SWSC @MayoAZSurg
Hor Hoe Yan retweeted
Hallway buddies made it! 🎉
So proud of these surgeons-to-be. Congrats @HorBrandenburg @TanPoHong2 ! 🎊
#Match2025 #MatchDay
Hor Hoe Yan retweeted
Happy to share that 2 abstracts submitted have been accepted for presentation at SSAT/DDW! Would not have done it without the amazing mentorship and support from @MayoAZSurg #DDW2025
